Emor

Marble Arch Research, Inc. Initiates Research Coverage of Healixa Inc.

Retrieved on: 
Monday, May 17, 2021

The sponsored research also carries a rating and a price target and can be accessed at https://emerginggrowth.com/marble-arch-research-report-healixa-inc-otc-p...\nIn the update report released today, Marble Arch Research notes that, \xe2\x80\x9cUsing a comps-based valuation approach, we believe EMOR should be trading at $2.8-$3.3 per share vs the prevailing $1.20.

Key Points: 
  • The sponsored research also carries a rating and a price target and can be accessed at https://emerginggrowth.com/marble-arch-research-report-healixa-inc-otc-p...\nIn the update report released today, Marble Arch Research notes that, \xe2\x80\x9cUsing a comps-based valuation approach, we believe EMOR should be trading at $2.8-$3.3 per share vs the prevailing $1.20.
  • For example, forward-looking statements are used when discussing our expected research and development programs, and more.
  • Except as otherwise required by law, Healixa Inc., f.k.a.
  • Emerald Organic Products, Inc., undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.\n'

Healixa Inc. Appoints Rep. Denver Riggleman to Advisory Board

Retrieved on: 
Monday, March 8, 2021

Holbrook, New York, March 08, 2021 (GLOBE NEWSWIRE) -- Emerald Organic Products Inc. (d/b/a Healixa Inc.) (OTC: EMOR) (the Company, "EMOR", Healixa), a people-first digital organization that humanizes care by deploying simplified solutions for complex global challenges, today announces that its Board of Directors (the Board) appointed Former U.S. Representative Denver Riggleman to its Advisory Board.

Key Points: 
  • Holbrook, New York, March 08, 2021 (GLOBE NEWSWIRE) -- Emerald Organic Products Inc. (d/b/a Healixa Inc.) (OTC: EMOR) (the Company, "EMOR", Healixa), a people-first digital organization that humanizes care by deploying simplified solutions for complex global challenges, today announces that its Board of Directors (the Board) appointed Former U.S. Representative Denver Riggleman to its Advisory Board.
  • Rep. Riggleman has thoroughly impressed the Board with both his business acumen and his deep understanding of our technologies, said Ian Parker, CEO of Healixa.
  • We are excited to have Rep. Reiggleman on our Advisory Board and look forward to working closely with him.
  • Healixa highly values the broad range of experience that Rep. Riggleman brings to the Advisory Board, which include government, defense, national security and executive management.

Emerald Organic Products Inc. Announces Corporate Name Change to Healixa, Solidifying a Position at the Tech Table

Retrieved on: 
Wednesday, February 24, 2021

Over the past year, EMOR has cemented its status as an emerging market leader in healthtech.

Key Points: 
  • Over the past year, EMOR has cemented its status as an emerging market leader in healthtech.
  • Healixa represents the expanded vision of the Company to capitalize on our unique combination of talent and technology, said Ian Parker, CEO of Healixa.
  • About Emerald Organic Products Inc.
    Emerald Organic Products Inc. has recently changed its name to Healixa Inc. in the State of Nevada and continues to trade under symbol OTC: EMOR.
  • Emerald Organic Products, Inc., undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

9/11 Charity Announces Hallowed Tradition Will Continue

Retrieved on: 
Thursday, August 6, 2020

Staten Island, NY, Aug. 06, 2020 (GLOBE NEWSWIRE) -- The annual, hallowed tradition of family members reading the names of the nearly 3,000 victims of the 9/11 attacks will take place again this year.

Key Points: 
  • Staten Island, NY, Aug. 06, 2020 (GLOBE NEWSWIRE) -- The annual, hallowed tradition of family members reading the names of the nearly 3,000 victims of the 9/11 attacks will take place again this year.
  • Tunnel to Towers decided to take this step after the National September 11 Memorial & Museum announced the reading of the names would not happen at the memorial ceremony this year, citing COVID-19 concerns.
  • The museum said a recording from their In Memoriam exhibition would be played instead.
  • However, not allowing families the opportunity to read the names of their loved ones robs this solemn ceremony of much of its significance.